Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
139(c) 134.6(c) 132.2(c) 132(c) 124(c) Last
8 190 11 582 11 408 7 272 14 423 Volume
-3.47% -3.17% -1.78% -0.15% -6.06% Change
More quotes
Estimated financial data (e)
Sales 2021 367 M 415 M 415 M
Net income 2021 58,1 M 65,8 M 65,8 M
Net Debt 2021 76,1 M 86,1 M 86,1 M
P/E ratio 2021 41,5x
Yield 2021 0,62%
Sales 2022 418 M 473 M 473 M
Net income 2022 72,1 M 81,6 M 81,6 M
Net Debt 2022 67,4 M 76,2 M 76,2 M
P/E ratio 2022 32,8x
Yield 2022 0,84%
Capitalization 2 373 M 2 687 M 2 685 M
EV / Sales 2021 6,67x
EV / Sales 2022 5,84x
Nbr of Employees 1 246
Free-Float 30,5%
More Financials
Company
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee... 
More about the company
Ratings of Medacta Group SA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MEDACTA GROUP SA
11/05Medacta marks its GMK Sphere 10-year anniversary
PU
10/19MEDACTA : extends the personalized medicine concept to total knee revision surgeries with ..
PU
10/19Medacta Extends the Personalized Medicine Concept to Total Knee Revision Surgeries with..
CI
09/29MEDACTA : First Surgery with Medacta's Minimally Invasive M.U.S.T. MC Platform Read More >
PU
09/16MEDACTA : celebrates the milestone of 10,000 Medacta Shoulder System implanted worldwide!
PU
09/14MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral Recommendat..
MT
09/10MEDACTA : Swiss Medical Device Maker Medacta's H1 Profit Climbs as All Business Areas Expa..
MT
09/10MEDACTA : Press Release – 2021 Half-Year Results
PU
09/10MEDACTA : reports strong profitability with 31.9% adjusted EBITDA margin in the first seme..
PU
09/10MEDACTA : 2021 Half-Year Presentation
PU
09/10MEDACTA : 2021 Half-Year Report
PU
09/10Medacta Group SA Announces Unaudited Earnings Results for the Six Months Ended June 30,..
CI
09/10Medacta Group SA Confirms Revenue Guidance for the Year 2021
CI
09/09MEDACTA : Expands its Sports Medicine Innovative Portfolio with a Full Line of New Product..
PU
08/31MEDACTA : Showcases Personalized Solutions for orthopaedic and spine surgeons in same-day ..
PU
More news
News in other languages on MEDACTA GROUP SA
10/20Morning Briefing - Markt Schweiz
10/19Medacta stellt Knieprothese in 3D-Druck her
10/18AKTIEN SCHWEIZ : Treten an Ort - Anleger warten auf Firmenbilanzen
10/18BOURSE ZURICH : le SMI peine à trouver sa voie à l'approche de la mi-journée
09/30¿Un verano para nada?
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MOVE | CH0468525222 | MarketScreener
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 118,66 €
Average target price 134,50 €
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA50.68%2 822
ABBOTT LABORATORIES14.23%221 160
MEDTRONIC PLC-2.30%153 906
BECTON, DICKINSON AND COMPANY-2.30%69 432
HOYA CORPORATION27.96%59 234
DEXCOM, INC.61.90%58 016